News
In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...
Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on ...
A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...
FDA head Marty Makary said the agency may fast-track drugs from companies that “equalize” the cost of medicines between the U ...
CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of ...
Explore more
The science that led to Zantac’s withdrawal is very different from the basis of the recently dismissed Zantac litigation (“The Zantac Scare and Junk Science,” Review & Outlook, Dec. 9). The ...
Zantac pharma exec calls heartburn drug safe and effective during testimony against cancer claims The executive, a medical doctor who oversaw drug safety for decades at drugmaker GSK, ...
Logically Answered on MSN3d
Why 77,000 cancer patients are suing pfizer & othersThe Shocking Truth" How did Zantac, once the world's most popular drug for acid reflux and heartburn, turn into a toxic nightmare linked to cancer and massive lawsuits? In this video, we uncover the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results